Bright ideas, new partnerships, and fun on tap at SCOPE 2022

This year’s Summit for Clinical Ops Executives (SCOPE) event, scheduled February 7-10, looks much different than the event of just two years ago, with a program that’s taking place both in person in Orlando, Florida, and in the virtual realm. Despite the challenges, however, one characteristic remains the same: SCOPE 2022 is still a place to share new ideas and innovations.

Micah Lieberman, executive director of conferences for SCOPE organizer Cambridge Healthtech Institute (CHI), spoke with Outsourcing-Pharma about what’s on tap for this year’s gathering.

OSP: This is now the second SCOPE to take place after COVID arrived. Can you please talk about some of the impacts the pandemic has had on the industry?

ML: It’s hard to believe that we are approaching the two-year mark! These continue to be scary and frustrating times, but let’s focus on some of the silver linings for a moment.

The development of the COVID vaccine is a huge story way beyond the biopharma industry and the fact that one of the greatest feats in modern science was accomplished by our industry despite all the political turmoil happening in parallel is amazing. It was good to see the industry in a positive light in the press and it was even better to see regular people talking about clinical trials.

The other thing is that COVID was a huge accelerant for a lot of innovation already underway inside of the industry (patient-centric trials, decentralized trials, etc.) and it allowed companies and regulatory bodies to commit beyond pilots. Our CHI team continues to pivot and provide updates for our attendees in both an in-person and virtual format.